Recent Advances of Novel Pharmaceutical Designs for Anti-cancer Therapies

• Autres auteurs: Biersack, Bernhard (Éditeur intellectuel)
• Format: Électronique Chapitre de livre
• Langue: anglais
• Publié: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
• Sujets: Medicine; Oncology; illudin M; retinoic acid; neuronal cells; brain tumors; anticancer agents; PROTAC; target protein; protein degradation; indication; cinnamic acid derivatives; antiproliferative activity; microtubule; tubulin stabilizer; pterostilbene; melanoma; anticancer activity; apoptosis; proliferation; hepatocellular carcinoma; eIF4A1; translation inhibitors; targeted therapies; heat shock proteins; Hsp70; Hsp40; anticancer; eEF1A; mechanism; macrocycle; heterocycle; gold; carbene ligands; metal-based drugs; esophageal cancer; carbonic anhydrases; colorectal cancer; consensus molecular subtypes; CMS; SLC-0111; targeted inhibition of carbonic anhydrases; chemotherapy; curcumin; difluorinated curcumin; CDF; pancreatic cancer; PDAC; 2-hydroxypropyl-β-cyclodextrin; cyclodextrin; adenosine deaminases acting on RNA (ADAR); anti-ADAR2; natural products; cancer; depression; anxiety disorders; autism spectrum disorder (ASD); molecular docking; molecular dynamics simulation; n/a
• Accès en ligne: DOAB: download the publication; DOAB: description of the publication

This Special Issue covers a well-balanced collection of state-of-the-art topics in the prospering and competitive field of anticancer drug design and development, which can address and inspire oncologists, biologists, and medicinal chemists among the readership of this journal.